The FDA seeks to outlaw vitamin B6

The FDA seeks to outlaw pyridoxamine (vitamin B6)

Your first thought might be, "How could it matter?" Lots of companies trademark names of ingredients. Heck, I've done it with some of my formulations. But in those cases, you're just talking about marketing differentiation. But with Polyphenon E, you have a whole different ballgame.

First, think about the status of green tea in the world. It's only known side effect is that it might make it more difficult for you to sleep if you took too much of it too close to bedtime. In exchange for this minor effect, you get all of the benefits cited above (cancer, heart disease, longevity, etc.), all demonstrated in study after study after study. In point of fact, you would be hard pressed to find a single drug in the world that has so few side effects and so many benefits and so many studies to back it up. Even the so-called miracle drug, aspirin, is not as clean. Remember, the smallest dosage of aspirin causes internal bleeding.

And yet, given green tea's remarkable safety record and proven benefits, not a word of these benefits can be mentioned in connection with any product being sold that contains green tea -- not in the US, not in Europe, not anywhere. And yet, Polyphenon E is being pitched as a potential cancer cure all over the internet and in medical literature. It even has a featured position on the Prostate Cancer Foundation website. How can this be?

Perhaps we can find the answer by looking at the curious case of pyridoxamine – the only form of B6 that can be taken without fear of peripheral neuropathy, and the only form, according to some experts, that should ever be used in supplements. And yet, given all this, pharmaceutical interests have filed a petition with the FDA seeking to ban the use of pyridoxamine in supplements. And the FDA is seriously considering it. Why? Because pyridoxamine has shown promise in protecting against diabetic complications! According to the FDA, if low cost pyridoxamine was available in supplements, there would be no incentive for the pharmaceutical industry to invest the money necessary to get it classified as a prescription drug! In other words, if there is enough money involved, the FDA is quite willing to reclassify everyday supplements as pharmaceutical drugs.

For a more detailed look at this issue, check out William Faloon's article in the most recent issue of Life Extension Magazine.